Shanghai, China, August 21, 2015 - the German pharmaceutical giant boehringer ingelheim and Shanghai zhangjiang biomedical base development co., LTD., today announced that the cooperation of the construction of the boehringer ingelheim Chinese biopharmaceutical manufacturing building a smooth transition. The handover of the building marks the boehringer ingelheim Chinese biopharmaceutical base construction process is an important step, plays an important role in the development of the industrialization of biological medicine in Shanghai, and will accelerate the construction of Shanghai kechuang center with global influence.

Shanghai zhangjiang biomedical base development co., LTD. General manager Mr Wang Lanzhong said: "today, we would be glad to manufacture building handover smoothly to boehringer ingelheim company, believe boehringer ingelheim quickly into line with international standards of professional equipment, process, technology and standards, which will be conducive to advance our zhangjiang a large number of research and development enterprises rapid industrialization of innovation, for the further development of Shanghai and the biopharmaceutical industry in China to create conditions."